Argentum

Recent Posts

CDC Recommends mRNA Vaccines Over Johnson & Johnson

Posted by Argentum on December 17, 2021

The CDC yesterday announced that it is preferable to get an mRNA vaccine—such as Pfizer or Moderna in a two-shot series—over the Johnson & Johnson one-shot vaccine.  

Read More

Topics: Vaccine

Boosters Recommended for Ages 16-17; Preventive Use of Monoclonal Antibodies Gets EUA

Posted by Argentum on December 9, 2021

CDC director Dr. Rochelle Walensky today announced that the CDC recommends and encourages booster shots for ages 16 and 17, as well as reinforcing the previous announcement that those older than 18 get the booster.  

Read More

Topics: Vaccine

Updated Testing Information Available

Posted by Argentum on December 8, 2021

With the increase in cases of the Omicron COVID variant, the FDA and CDC have announced some updates that can help guide testing decisions and action. 

Read More

Topics: Testing

CDC Says 18+ ‘Should’ Get Booster

Posted by Argentum on December 1, 2021

The CDC made a change to its recommendations, saying “Everyone ages 18 and older should get a booster shot.” Previously, the CDC had said everyone “may” get a booster. This stronger recommendation comes in the wake of the emergence of the Omicron variant and the prospect of winter holidays, travel, and close quarters.  

Read More

Topics: Vaccine

COVID Pill Treatment Closer to Emergency Use Authorization

Posted by Argentum on December 1, 2021

The Antimicrobial Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended emergency use authorization (EUA) of molnupiravir. The oral capsule medication made by Merck is designed to treat “mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization,” says the FDA.  

Read More

Topics: Guidance

Omicron Variant: Resources to Keep Up with the Changing Picture

Posted by Argentum on November 29, 2021

While the World Health Organization has classified a new variant of the coronavirus, Omicron, as a “variant of concern,” as of Nov. 26, no cases have been reported in the United States.

Read More

Topics: Vaccine

Boosters for All Move Goes to CDC Committee

Posted by Argentum on November 19, 2021

The U.S. Food and Drug Administration has authorized a single booster dose for all individuals 18 and older who have had their primary vaccinations. The booster would be given six months after the primary series with Moderna or Pfizer, and two months after Johnson & Johnson.

Read More

Topics: Vaccine

Vaccine Approved for Ages 5 to 11

Posted by Argentum on November 2, 2021

CDC director Dr. Rochelle Walensky gave the go-ahead for vaccination of 5- to 11-year-olds against COVID-19, following the recommendations of the FDA and the CDC Advisory Committee on Immunization Practices (APIC).

Read More

Topics: Vaccines

CDC OKs Fourth Shot for Immunocompromised

Posted by Argentum on October 27, 2021

The CDC has updated guidance for people who are moderately to severely immunocompromised: 

Read More

Topics: Vaccine

FDA Committee Recommends Allowing Vaccine for Ages 5-11

Posted by Argentum on October 27, 2021

A U.S. Food and Drug Administration advisory committee has recommended authorization of Pfizer-BioNTech pediatric vaccine for ages 5 to 11.  

Read More

Topics: Vaccine

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:

SEE BLOG

Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.

SEE TOOLKIT